Česky English

+420 511 181 555

info@iccti.eu

5th ANNUAL CONFERENCE OF ICCTI

5th ANNUAL CONFERENCE OF ICCTI

Program topics:
1. Stem cells – from biology to clinical application
2. Cell-therapies and regulations
3. Adipose tissue in regenerative medicine
4. Cell-based immunotherapy

May 15 – 16, 2015
Hotel Karel V, Utrecht, The Netherlands

For downloading Abstract book click here

Day 1, Friday, May 15, 2015
13:00 – 13:30 Registration
Block 1: Stem cells – from biology to clinical application
Chair: J. Michalek
13:30 – 14:00 Dr. A. Darinskas (National Cancer Institute, Lithuania) – Stem cells in regenerative medicine
14:00 – 14:30 Dr. T. K. Malan (Okyanos Heart Institute, USA) – Understanding the role of Adipose Stem Cells in the spectrum of Degenerative Diseases
14:30 – 15:00 Dr. G. Grinsendi (University Hospital of Modena and Reggio Emilia, Italy) – Engineering Adipose Mesenchymal Progenitors for Cancer Therapy
15:00 – 15:30 Prof. E. Chernykh (Institute of Fundamental and Clinical Immunology, Russia) – Macrophages as new candidate cells for stroke treatment
15:30 – 16:00 Prof. N. Zakaria (University of Antwerp, Belgium) – Corneal Regeneration – From the Lab to the Clinic and Back
16:00 – 16:30 Coffee break
Block 2: Cell-therapies and regulations
Chair: T. K. Malan
16:30 – 17:00 Prof. J. Michalek (ICCTI, Brno, Czech Republic) – Legal issues in cell therapies and EU Regulations + ICCTI Letter to EMA
17:00 – 17:30 Dr. T. Stasch (Plastic Surgeon, Germany) – The DEALTH Method – How we can improve Wound Healing of Chronic Ulcers of the Lower Limb and Diabetic Feet using Autologous Lipotransfer
17:30 – 18:00 Dr. K. Freitag (President of the Spanish society for schockwave SETOC, Spain) – Biological effects of Shockwave therapy
18:00 – 18:30 Prof. E. Martinez-Caceres (IGTP, Badalona, Spain) – Cell therapy with tolerogenic dendritic cells for autoimmune diseases
19:00 Dinner and networking
Day 2, Saturday, May 16, 2015
Block 3: Adipose tissue in regenerative medicine
Chair: K. Ueberreiter
9:00 – 9:30 Dr. HJ Duckers (University Medical Center, Netherland) – Hype or Hope: The future of adipose-derived stem cells in cardiovascular disease
9:30 – 10:00 Prof. M. Harmsen (PI Cardiovascular Regenerative Medicine Group, Netherlands) and Dr. M. Spiekmann (University Groningen, Netherlands) – Adipose-derived stromal cells for soft tissue reconstruction and regeneration: future or fiction?
10:00 – 10:30 Prof. J. Michalek (Brno, Czech Republic) – Adipose-derived cells in orthopedics
10:30 – 11:00 Prof. D. Garcia-Olmo (Fundacion Jimenez Diaz University Hospital, Spain) – Adipose Derived Stem cells in Crohn Disease
11:00 – 11:30 Prof. O. Tapparo (Germany) – Risk factor oral cavity, treatment with autologous blood factors (plasma-, growth factors and stem cells)
11:00 – 11:30 Dr. E.A. Blinova (Institute of Fundamental and Clinical Immunology, Russia) – T-cell vaccines in the treatment of atopic dermatitis and multiple sclerosis
12:00 – 12:55 Lunch break
Block 4: Cell-based immunotherapy
Chair: V. Schijns
12:55 – 13:00 Prof. V. Schijns – Introduction note
13:00 – 13:30 Dr. M. Strioga (National Cancer Institute, Lithuania) – Dendritic cell-based vaccines for the treatment of recurrent glioblastoma multiforme
13:30 – 14:00 Dr. E. Smits (Antwerpen University, Belgium) – Vaccination with WT1 mRNA-Electroporated Dendritic Cells: Report of 66 Cancer Patients
14:00 – 14:30 Dr. M. Glassy (Nascent Biotech Inc., USA) – Pritumumab – a clue to using the natural human immune response for drug development
14:30 – 15:00 Dr. H. Dolstra (Nijmegen Radboud University, Netherland) – Cancer immunotherapy with ex vivo-generated NK cells from hematopoietic progenitor cells
15:00 – 15:30 Dr. N. Cools (University of Antwerp, Belgium) – The pursuit of tolerance: Immunomodulation of dendritic cells for therapeutic intervention in multiple sclerosis
15:30 – 16:00 Dr. E. Ya. Shevela (Institute of Fundamental and Clinical Immunology, Russia) – Immunomodulatory effects of mesenchymal stromal cells in lymphoma patients following HSC transplantation
16:00 End of Conference

© 2017 ICCTI. Mezinárodní konsorcium pro buněčnou terapii a imunoterapii | registrační číslo projektu: CZ.1.07/2.3.00/20.0012